Cloxacillin Dosing for Thrombophlebitis in Adults
For superficial thrombophlebitis caused by methicillin-susceptible Staphylococcus aureus (MSSA), cloxacillin should be dosed at 12 g per day intravenously, divided into 4-6 doses (typically 2 g every 4 hours), for 7-10 days. 1, 2
Standard Dosing Regimen
- Cloxacillin (or flucloxacillin/oxacillin): 12 g/day IV divided into 4-6 doses 1, 2
- Alternative dosing: 2 g every 4 hours IV (six times daily) 2
- Duration: 7-10 days for uncomplicated skin and soft tissue infections 1, 3
Clinical Context and Pathogen Coverage
Thrombophlebitis is typically classified as a skin and soft tissue infection (SSTI), most commonly caused by MSSA when bacterial in origin 1, 4, 5. Cloxacillin represents the parenteral drug of choice for MSSA infections due to its narrow spectrum and excellent anti-staphylococcal activity 1, 6.
Alternative Agents for MSSA
If cloxacillin is unavailable or not tolerated:
- Nafcillin or oxacillin: 1-2 g every 4 hours IV 1, 3
- Cefazolin: 1 g every 8 hours IV (for non-anaphylactic penicillin allergy) 1, 3
- Vancomycin: 15-20 mg/kg/dose IV every 8-12 hours (for severe penicillin allergy or MRSA) 1, 3
MRSA Coverage Considerations
If methicillin-resistant S. aureus (MRSA) is suspected or confirmed:
- Vancomycin: 15-20 mg/kg/dose IV every 8-12 hours 3, 5
- Linezolid: 600 mg IV/PO every 12 hours 3, 5
- Daptomycin: 4 mg/kg IV every 24 hours for SSTI 3
Important Pharmacokinetic Considerations
Cloxacillin dosing should be adjusted based on renal function, as glomerular filtration rate significantly impacts drug clearance 7. For patients with severe renal impairment (GFR <30 mL/min), dose reduction or interval extension may be necessary, though specific guidelines are limited 7.
The standard 12 g/day dosing achieves adequate time above MIC (T>MIC) of approximately 50% when given as 2 g every 4 hours, which exceeds the recommended 40% threshold for optimal bactericidal activity 6.
Administration and Monitoring
- Infusion phlebitis risk: Cloxacillin has a moderate tendency to cause infusion phlebitis compared to dicloxacillin or erythromycin 8
- Continuous infusion alternative: For severe infections like endocarditis, continuous infusion may be considered with target steady-state concentrations of 20-50 mg/L 7
- Monitoring: Assess clinical response within 48-72 hours; consider alternative diagnosis or MRSA coverage if no improvement 4, 5
Duration and Transition to Oral Therapy
For uncomplicated superficial thrombophlebitis, transition to oral therapy after clinical improvement (typically 3-5 days) may be appropriate 1, 3: